Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1971 Oct;4(4):479–487. doi: 10.1128/iai.4.4.479-487.1971

Inhibition of Pseudomonas aeruginosa by Hyperbaric Oxygen I. Sulfonamide Activity Enhancement and Reversal

Leonard M Pakman 1
PMCID: PMC416335  PMID: 5005304

Abstract

To elucidate an explanation for in vitro sulfonamide enhancement by high-pressure oxygen (HPO) and the reported absence of enhancement with in vivo therapy, Pseudomonas aeruginosa cultures were exposed to selected antifolate antimicrobials in the presence of 1.87 atm absolute of O2 and compared with non-HPO treated controls. Under these conditions, HPO alone retarded growth. Trimethoprim, a non-sulfonamide which inhibits dihydrofolate reductase, was not bactericidal, nor did HPO enhance existent bacteriostatic activity. The sulfonamide, sulfisozazole, was not bactericidal, but HPO enhanced bacteriostatic activity twofold; bacteriostasis was mitigated in HPO-treated and control cultures by p-aminobenzoate but not by a mixture of compounds involved in folate-mediated “1-C” biosynthesis. Mafenide, a unique sulfonamide, at high concentrations with HPO, was synergistically bactericidal; non-HPO-treated cultures were bacteriostatically inhibited. Bacteriostatic activity of lower mafenide concentrations was also enhanced at least twofold by HPO. These inhibitory effects of mafenide, acting with or without HPO, were mitigated by the above mixture, but not by p-aminobenzoate. This may explain the lack of in vivo HPO-mafenide enhancement in burn-wound sepsis where exudates would contain such a mixture. Lastly, HPO itself was largely bactericidal at 2.87 atm absolute of O2. This was reversed to various degrees by the above mixture, or its components, or by folic, folinic, or p-aminobenzoic acids. These in vitro interactions suggest HPO per se may act at the same site as some sulfonamides to inhibit folate synthesis (not primarily at the dihydrofolate reductase level), or coenzyme functions of folate, or both.

Full text

PDF
479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Argamaso R. V., Wiseman G. M. The use of combined hyperbaric oxygen and Polymyxin B in the treatment of Pseudomonas infections of mice. Plast Reconstr Surg. 1967 Jul;40(1):81–85. doi: 10.1097/00006534-196707000-00014. [DOI] [PubMed] [Google Scholar]
  2. BROWN G. M. The biosynthesis of folic acid. II. Inhibition by sulfonamides. J Biol Chem. 1962 Feb;237:536–540. [PubMed] [Google Scholar]
  3. Bornside G. H. Exposure of Pseudomonas aeruginosa to hyperbaric oxygen: inhibited growth and enhanced activity of polymyxin B. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1152–1156. doi: 10.3181/00379727-125-32301. [DOI] [PubMed] [Google Scholar]
  4. Bornside G. H., Nance F. C. High-pressure oxygen combined with antibiotics in the therapy of experimental burn wounds. Antimicrob Agents Chemother (Bethesda) 1968;8:497–500. [PubMed] [Google Scholar]
  5. Brown O. R., Silverberg R. G., Huggett D. O. Synergism between hyperoxia and antibiotics for Pseudomonas aeruginosa. Appl Microbiol. 1968 Feb;16(2):260–262. doi: 10.1128/am.16.2.260-262.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Coupland R. E., MacDougall J. D. The effect of hyperbaric oxygen on rat liver cells in organ culture: a light- and electron-microscope study. J Pathol Bacteriol. 1968 Jul;96(1):149–159. doi: 10.1002/path.1700960116. [DOI] [PubMed] [Google Scholar]
  7. GOTTLIEB S. F., ROSE N. R., MAURIZI J., LANPHIER E. H. OXYGEN INHIBITION OF GROWTH OF MYCOBACTERIUM TUBERCULOSIS. J Bacteriol. 1964 Apr;87:838–843. doi: 10.1128/jb.87.4.838-843.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gottlieb S. F. Bacterial nutritional approach to mechanisms of oxygen toxicity. J Bacteriol. 1966 Oct;92(4):1021–1027. doi: 10.1128/jb.92.4.1021-1027.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gottlieb S. F., Pakman L. M. Effect of high oxygen tensions on the growth of selected, aerobic, gram-negative, athogenic bacteria. J Bacteriol. 1968 Mar;95(3):1003–1010. doi: 10.1128/jb.95.3.1003-1010.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HAUGAARD N. HYPERBARIC OXYGENATION. POISONING OF CELLULAR REACTIONS BY OXYGEN. Ann N Y Acad Sci. 1965 Jan 21;117:736–744. [PubMed] [Google Scholar]
  11. Hitchings G. H., Burchall J. J. Inhibition of folate biosynthesis and function as a basis for chemotherapy. Adv Enzymol Relat Areas Mol Biol. 1965;27:417–468. doi: 10.1002/9780470122723.ch9. [DOI] [PubMed] [Google Scholar]
  12. Irvin T. T., Norman J. N., Suwanagul A., Smith G. Hyperbaric oxygen in the treatment of infections by aerobic microorganisms. Lancet. 1966 Feb 19;1(7434):392–394. doi: 10.1016/s0140-6736(66)91390-0. [DOI] [PubMed] [Google Scholar]
  13. Joanny P., Corriol J., Brue F. Hyperbaric oxygen: effects on metabolism and ionic movement in cerebral cortex slices. Science. 1970 Mar 13;167(3924):1508–1509. doi: 10.1126/science.167.3924.1508. [DOI] [PubMed] [Google Scholar]
  14. Noguchi T. T., Strasser F. F., Nishihara H. Hyperbaric oxygen toxicity on tissue-culture cells. I. Light-microscopic study. Am J Pathol. 1967 Aug;51(2):243–257. [PMC free article] [PubMed] [Google Scholar]
  15. Stonehill E. H., Hutchison D. J. Chromosomal mapping by means of mutational induction in synchronous populations of Streptococcus faecalis. J Bacteriol. 1966 Jul;92(1):136–143. doi: 10.1128/jb.92.1.136-143.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Zaroff L. I., Walker H. L., Lowenstein E., Evans B. W., Kroos L. S. Hyperbaric oxygenation in aerobic infections. Arch Surg. 1965 Oct;91(4):586–588. doi: 10.1001/archsurg.1965.01320160040008. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES